New law prioritizes patient health and patient access, protecting Texans’ ability to receive pharmacy services from their chosen pharmacy provider.
The bill was signed into law by Texas Governor Greg Abbott (R) on Wednesday, May 26.
New law vital for the viability of community pharmacies and to help ensure access to patient care in Alabama.
NACDS notes that the Supreme Court's ruling also is extremely significant for the residents of approximately 40 other states that have enacted similar laws.
The U.S. Supreme Court will review the Eighth Circuit Court’s decision that put the brakes on Arkansas’ PBM law that would ensure that pharmacy reimbursement rates cover pharmacies’ costs of purchasing drugs.
The National Community Pharmacists Association, the National Association of Chain Drug Stores, and the National Association of Specialty Pharmacy issued a statement regarding the Centers for Medicare & Medicaid Services’ release on Monday of the proposed rule titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses."
The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.
The Patient Right to Know Drug Prices Act (S. 2554) is part of the effort to empower pharmacists to help patients lower out-of-pocket drug costs.
DIR fee reform, health-and-wellness expansion top Business Program agenda; NACDS communicates from Denver to Washington, D.C. about trade war’s risks.
NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.
